Business interruption and COVID-19: A UK perspective
On January 15, 2021, the United Kingdom’s Supreme Court (“Court”) issued a decision which is likely to be viewed as good news for policy holders who have endured business interruption losses arising from the COVID-19 pandemic.
In response to the widening denial of business interruption claims under the standard wording of insurance policies, the Financial Conduct Authority, the regulator of various UK insurers, advanced a test case with the aim of providing interpretive guidance from the courts to the insurance market for the interpretation of certain standard clauses in insurance contracts.
While not binding in Canada, the analysis undertaken by the UK Supreme Court in Financial Conduct Authority v Arch Insurance (UK) Ltd and Others,  UKSC 1 will be informative to Canadian decision makers where litigation ensues following the denial of coverage in relation to the following types of clauses:
- Disease clauses: Clauses which, in general, provide for cover for business interruption losses resulting from the occurrence of a notifiable disease, such as COVID-19, at or within a specified distance of the business premises;
- Prevention of access clauses: Clauses which, in general, provide for cover of business interruption losses resulting from public authority intervention preventing or hindering access to, or use of, the business premises;
- Hybrid clauses: Clauses which combine main elements of the disease and prevention of access clauses; and
- Trends clauses: Clauses which, in general, provide for business interruption loss to be quantified by reference to what the performance of the business would have been had the insured peril not occurred.
Further widening the decision of the High Court, the Court expanded the notion that “restrictions imposed” to prevent access must be undertaken by “force of law.” Additionally, the interpretation of an “inability to use” one’s premises as a result of the restrictions imposed was also widened, such that it is not required that the whole of the premises be unusable for any business purpose. For example, a restaurant may only be able to offer takeout service, while still being covered for losses stemming from its inability to use its premises for the dine-in aspect of its business as a result of COVID-19.
The analysis undertaken by the UK Supreme Court will be informative though non-binding to judicial decision makers in Canada where litigation ensues with regard to these types of clauses, which are also frequently found in the Canadian insurance market.
Brian Johnston, QC, Killian McParland and Bhreagh Ross On April 6, 2021, Stewart McKelvey was advised by the Federal Labour Program that the Labour Program’s Forward Regulatory Plan 2021–23 (“Plan”) is now available and includes details and timing on 21…Read More
Jennifer Taylor and Bhreagh Ross In the recent Reference re Greenhouse Gas Pollution Pricing Act (“GGPPA Reference”), the judges of the Supreme Court of Canada unanimously agreed that climate change is real and dangerous.…Read More
We are pleased to present the fifth installment of Beyond the border, a publication aimed at providing the latest information to clients about new programs and other immigration-related information that may be pertinent to employers of…Read More
Richard Jordan Is a worker under a contract “of” service or contract “for” service? The former means a worker is an employee whereas the latter means a worker is an independent contractor. The answer to…Read More
Kevin Landry and William Wojcik In September 2020 the Supreme Court of Canada heard Reference re Greenhouse Gas Pollution Pricing Act, 2021 SCC 11, a case featuring appeals from Ontario, Saskatchewan, and Alberta with respect to…Read More
Christopher Marr, TEP and David Slipp Effective March 1, 2021 in all provinces of Canada, other than Ontario and Quebec (to be effective there on July 1, 2021), securities laws related to the distribution of…Read More
Kevin Landry and Emily Murray On March 8, 2021, Health Canada released draft guidance on personal production of cannabis for medical purposes (“Guidance Document”). At present, the Guidance Document is being circulated for public comment for…Read More